To deliver the program, MTPConnect is partnering with research, training and industry organisations to deploy an integrated, three-pillar plan driving skills development and workforce training that brings together researchers, clinicians, industry and the entrepreneurial ecosystem.
MTPConnect Managing Director & CEO, Dr Dan Grant has welcomed the awarding of the program, which he says MTPConnect is uniquely placed to deliver.
“Our REDI program is all about ensuring Australia has an industry-ready MTP workforce with the skills necessary to keep pace with a rapidly changing sector,” he said.
“We’ll leverage a national alliance of proven education and training providers, research institutes and industry partners to deploy a range of activities and initiatives – all focused on enhancing the MTP sector workforce.
“As we roll out our REDI program, we’re thrilled to be working with partners including, The George Institute for Global Health, APRIntern, Industry Mentoring Network in STEM (IMNIS), the Victorian Comprehensive Cancer Centre (VCCC), the Medical Device Partnering Program (MDPP), MedTech Actuator, the Bridge and BridgeTech programs (Queensland University of Technology) and ANDHealth.
“The program will also leverage the expertise and experience of Research Australia, CSL, Innovative Manufacturing CRC, the Medical Technology Association of Australia (MTAA), Pharmaceutical Manufacturing Industry Reference Committee, the University of NSW and the NSW Office of Health and Medical Research,” Dr Grant said.
In addition to the program partners and associates, MTPConnect Chair Sue MacLeman says the MTPConnect REDI program will be engaging widely across Australia’s MTP sector.
“The MTPConnect REDI program has a national remit and sector-wide focus,” she said.
“Our program will provide researchers across Australia with a diverse range of experiences and exposure to entrepreneurism with the aim of strengthening Australia’s success with translation and commercialisation.
“The MTPConnect REDI program will also systematically address current gaps in workforce skills and put in place programs to meet the challenge of developing and retaining world-class talent who have industry experience in research translation, clinical development and commercialisation.”